- Monitoring EBV infection, MSI, PDL-1 expression, Her-2/neu amplification as a biomarker for PD-1 inhibition in gastric cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- First-line pembrolizumab for metastatic non-small-cell lung cancer2020 | First Faculty of Medicine
- Detection of Circulating Tumor Cells in Renal Cell Carcinoma: Disease Stage Correlation and Molecular Characterization2020 | First Faculty of Medicine, Third Faculty of Medicine
- PD-L1 testing - new challenge in predictive diagnostics of non-small cell lung carcinoma2016 | Faculty of Medicine in Hradec Králové
- Immunotherapy in the treatment of non-small cell lung cancer2017 | Faculty of Medicine in Pilsen
- NF-kappa B, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment2015 | Second Faculty of Medicine
- Predictive markers in breast cancer2021 | First Faculty of Medicine
